Order Article Reprints

Ghebeh H, Mirza JY, Mohammed SF, Khoja HA, Dababo MA, Tukruni ME, Anwar MS, Aldehaim M, Al-Rajhi N. High Tumoral CD24 Expression and Low CD3⁺ Tumor-Infiltrating Lymphocytes as a Biomarker for High-Risk Locally Advanced Nasopharyngeal Carcinoma. Cancers. 2025; 17(13):2094. https://doi.org/10.3390/cancers17132094

Ghebeh, Hazem, Jumanah Y. Mirza, Shamayel F. Mohammed, Hatim A. Khoja, Mohammad Anas Dababo, Muruj E. Tukruni, Muhammad S. Anwar, Mohammed Aldehaim, and Nasser Al-Rajhi. 2025. "High Tumoral CD24 Expression and Low CD3⁺ Tumor-Infiltrating Lymphocytes as a Biomarker for High-Risk Locally Advanced Nasopharyngeal Carcinoma" Cancers 17, no. 13: 2094. https://doi.org/10.3390/cancers17132094

Ghebeh, H., Mirza, J. Y., Mohammed, S. F., Khoja, H. A., Dababo, M. A., Tukruni, M. E., Anwar, M. S., Aldehaim, M., & Al-Rajhi, N. (2025). High Tumoral CD24 Expression and Low CD3⁺ Tumor-Infiltrating Lymphocytes as a Biomarker for High-Risk Locally Advanced Nasopharyngeal Carcinoma. Cancers, 17(13), 2094. https://doi.org/10.3390/cancers17132094